Sarcoma and Rare Cancers 2024 – Sarcoma and Rare Cancers 2024
All times are listed in CET (Central European
All times are listed in CET (Central European
PF-07220060 plus endocrine therapy was tolerable and generated robust response rates in HR-positive, HER2-negative metastatic breast cancer.
The OncoAlert Newsletter is now out for June 23-29, 2023
A study found that a novel ointment improved symptoms in patients with cutaneous T-cell lymphoma. The treatment was well-tolerated with minimal adverse effects.
Cancer Questions is a podcast by Dana-Farber Cancer Institute that addresses some of the most common questions surrounding cancer risk and prevention.
This cross-sectional study examines disparities in cancer treatment delay or discontinuation among US patients with cancer and SARS-CoV-2 by race and ethnicity across 5 waves…
Abstract. Clonal hematopoiesis (CH) is a phenomenon of clonal expansion of hematopoietic stem cells driven by somatic mutations affecting certain genes. Recently, CH has been…
Decades of research has dramatically changed cancer care, with more breakthrough treatments on the way thanks to clinical trials that pair patients with oncology experts.
Sattva S. Neelapu, MD, discusses the optimal processes of CAR T-cell therapy administration and the remaining unmet needs in the space.
AbstractBackground:. Ultrafine particles (UFP) are unregulated air pollutants abundant in aviation exhaust. Emerging evidence suggests that UFPs may impact lung health due to their high…
Thoracic anesthesia is a specialized procedure that allows one lung to continue breathing under anesthesia while the other lung is operated on. Stephanie Bradley, M.D.,…